Find all
associated with


Refine your query (more in Advanced-Search):
 Focus on the recent 5 years   Focus on the current year   Focus on the last 30 days   More choices ...
 Focus on articles with free fulltexts   More choices ...
 Do simple 'keyword' search (no query expansion)

[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 1253211
1. Zhang AY, Ji XW, Zhang AJ, Guan LX, Huang J, Wang JX: Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease. Cardiol Res; 2010 Dec;1(1):8-14
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease.
  • All patients were detected I/D polymorphism of angiotensin-converting enzyme (ACE) gene, 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene, and G894→T mutation of endothelial nitric oxide synthase (eNOS) gene.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Atherosclerosis. 2007 Nov;195(1):172-80 [17118372.001]
  • [Cites] Circulation. 1997 May 20;95(10):2358-67 [9170397.001]
  • [Cites] Eur Heart J. 2002 Dec;23(24):1955-62 [12473258.001]
  • [Cites] J Mol Cell Cardiol. 2005 Oct;39(4):667-79 [16087188.001]
  • [Cites] IUBMB Life. 1999 Aug;48(2):205-7 [10794598.001]
  • [Cites] Circulation. 1996 May 1;93(9):1630-3 [8653866.001]
  • [Cites] Diabetes. 2006 Jul;55(7):2140-7 [16804086.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):33-7 [9012634.001]
  • [Cites] Scand J Clin Lab Invest. 1998 Oct;58(6):491-5 [9832341.001]
  • [Cites] Heart. 2002 Jun;87(6):525-8 [12010932.001]
  • [Cites] Biochemistry. 1989 Jun 27;28(13):5311-8 [2476171.001]
  • [Cites] J Am Coll Cardiol. 1996 Jul;28(1):162-7 [8752809.001]
  • [Cites] J Biol Chem. 1993 May 25;268(15):10739-45 [8388372.001]
  • [Cites] Thromb Haemost. 2000 Jul;84(1):78-82 [10928474.001]
  • [Cites] Circulation. 1999 Oct 5;100(14):1515-20 [10510054.001]
  • [Cites] Coron Artery Dis. 2006 Feb;17(1):35-9 [16374139.001]
  • [Cites] Thromb Haemost. 1997 Mar;77(3):605-6 [9066021.001]
  • [Cites] Int J Cardiol. 2002 Nov;86(1):71-6 [12243851.001]
  • [Cites] Atherosclerosis. 1998 Jul;139(1):153-9 [9699903.001]
  • [Cites] Circulation. 1997 Jan 7;95(1):59-62 [8994417.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):152-6 [9484978.001]
  • [Cites] Thromb Res. 2001 Jul 15;103(2):103-7 [11457467.001]
  • [Cites] Hypertension. 1998 Sep;32(3):521-6 [9740620.001]
  • [Cites] Br J Haematol. 2000 Jul;110(1):135-8 [10930990.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2082-7 [9351375.001]
  • [Cites] Arch Pathol Lab Med. 2000 Apr;124(4):531-4 [10747309.001]
  • [Cites] Rev Cardiovasc Med. 2004;5 Suppl 3:S14-21 [15303081.001]
  • [Cites] Metabolism. 1998 Oct;47(10):1258-62 [9781631.001]
  • (PMID = 28352370.001).
  • [ISSN] 1923-2829
  • [Journal-full-title] Cardiology research
  • [ISO-abbreviation] Cardiol Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Keywords] NOTNLM ; Angiotensin-converting enzyme / Coronary artery disease / Endothelial nitric oxide synthase / Gene polymorphism / Major adverse cardiovascular event / Plasminogen activator inhibitor-1 / Prognosis
  •  go-up   go-down


2. Feng JX, Lin Y, Lin J, He SS, Chen MF, Wu XM, Xu YZ: Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity. J Korean Med Sci; 2017 Mar;32(3):439-447
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
  • This study explored the relationship between the fractional exhaled nitric oxide (FeNO) level and the efficacy of inhaled corticosteroid (ICS) in asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) patients with different disease severity.
  • We compared FeNO levels, pulmonary function parameters including percentage of forced expiratory volume in 1 second (FEV1) to predicted value (FEV1%pred), ratio of FEV1 to forced vital capacity (FEV1/FVC), inspiratory capacity to total lung capacity (IC/TLC) and residual volume to total lung capacity (RV/TLC), arterial blood gas parameters, including PH, arterial partial pressure of oxygen (PaO₂) and arterial partial pressure of carbon dioxide (PaCO₂), total serum immunoglobulin E (IgE), induced sputum eosinophil (EOS), plasma surfactant protein A (SP-A), plasma soluble receptor for advanced glycation end products (sRAGE), sputum myeloperoxidase (MPO), sputum neutrophil gelatinase-associated lipocalin (NGAL) and Asthma Control Test (ACT) scores, and COPD Assessment Test (CAT) scores.
  • [MeSH-major] Adrenal Cortex Hormones / therapeutic use. Asthma / drug therapy. Nitric Oxide / analysis. Pulmonary Disease, Chronic Obstructive / drug therapy
  • [MeSH-minor] Administration, Inhalation. Adult. Advanced Glycosylation End Product-Specific Receptor / blood. Aged. Biomarkers / blood. Biomarkers / metabolism. Blood Gas Analysis. Case-Control Studies. Female. Forced Expiratory Volume. Humans. Immunoglobulin E / blood. Lipocalin-2 / metabolism. Male. Middle Aged. Peroxidase / metabolism. Pulmonary Surfactant-Associated Protein A / blood. Respiratory Function Tests. Severity of Illness Index. Sputum / enzymology. Sputum / metabolism

  • Genetic Alliance. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - COPD.
  • MedlinePlus Health Information. consumer health - Steroids.
  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2015 Sep 24;10:2017-25 [26451099.001]
  • [Cites] J Allergy Clin Immunol. 2003 Nov;112(5):883-92 [14610474.001]
  • [Cites] Ann Allergy Asthma Immunol. 2014 Jan;112(1):18-22 [24331388.001]
  • [Cites] Respirology. 2016 Aug;21(6):1034-40 [27061430.001]
  • [Cites] Respiration. 2015;90(4):306-13 [26352833.001]
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86 [26251587.001]
  • [Cites] Expert Opin Pharmacother. 2015;16(12):1845-60 [26194213.001]
  • [Cites] Eur Respir J. 2009 Sep;34(3):648-54 [19720809.001]
  • [Cites] J Chin Med Assoc. 2013 Jan;76(1):15-9 [23331776.001]
  • [Cites] Expert Rev Respir Med. 2016;10 (3):363-71 [26789845.001]
  • [Cites] J Allergy Clin Immunol. 2004 Jan;113(1):59-65 [14713908.001]
  • [Cites] Biomed Res Int. 2014;2014:420134 [24683548.001]
  • [Cites] Eur J Anaesthesiol. 2016 Apr;33(4):275-82 [26716866.001]
  • [Cites] Respir Med. 2014 Jun;108(6):830-41 [24636813.001]
  • [Cites] Ther Adv Chronic Dis. 2016 Jan;7(1):34-51 [26770668.001]
  • [Cites] Eur Respir J. 2011 Mar;37(3):516-22 [20595148.001]
  • [Cites] Clin Physiol Funct Imaging. 2011 Jan;31(1):26-31 [21143751.001]
  • [Cites] Eur Respir J. 2016 Sep;48(3):664-73 [27338195.001]
  • [Cites] Nitric Oxide. 2014 Aug 31;40:110-6 [25014062.001]
  • [Cites] Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15 [21885636.001]
  • [Cites] Cent Eur J Public Health. 2015 Dec;23(4):286-91 [26841140.001]
  • [Cites] Oncotarget. 2016 May 3;7(18):25010-21 [26843624.001]
  • [Cites] Chest. 2010 Aug;138(2 Suppl):11S-17S [20668013.001]
  • [Cites] Eur Respir J. 2014 Feb;43(2):421-9 [23794464.001]
  • [Cites] Allergol Int. 2016 Jul;65(3):266-71 [26822895.001]
  • [Cites] J Korean Med Sci. 2011 Oct;26(10):1265-9 [22022176.001]
  • [Cites] J Asthma. 2015;52(10):1054-9 [26287987.001]
  • [Cites] Respiration. 2014;87(5):364-71 [24732295.001]
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2015 Oct 09;10:2169-76 [26491283.001]
  • [Cites] Am J Respir Cell Mol Biol. 2002 May;26(5):565-71 [11970908.001]
  • [Cites] Eur Respir J. 2016 Mar;47(3):751-68 [26846832.001]
  • [Cites] J Thorac Dis. 2014 Mar;6 Suppl 1:S146-51 [24672688.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Apr 15;171(8):912-30 [15817806.001]
  • [Cites] Allergol Int. 2015 Oct;64(4):359-63 [26433532.001]
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2016 Mar 04;11:479-87 [27019598.001]
  • [Cites] Health Technol Assess. 2015 Oct;19(82):1-330 [26484874.001]
  • [Cites] Tohoku J Exp Med. 2016;238(2):179-84 [26888697.001]
  • [Cites] J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):691-696.e1 [27039239.001]
  • (PMID = 28145647.001).
  • [ISSN] 1598-6357
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Advanced Glycosylation End Product-Specific Receptor; 0 / Biomarkers; 0 / Lipocalin-2; 0 / Pulmonary Surfactant-Associated Protein A; 31C4KY9ESH / Nitric Oxide; 37341-29-0 / Immunoglobulin E; EC 1.11.1.7 / Peroxidase
  • [Keywords] NOTNLM ; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome / Efficacy / Fractional Exhaled Nitric Oxide / Inhaled Corticosteroid
  •  go-up   go-down


3. Tabata K, Komori K, Otsuka R, Kajikuri J, Itoh T: Enhancement of Nitric Oxide Production Is Responsible for Minimal Intimal Hyperplasia of Autogenous Rabbit Arterial Grafts. Circ J; 2017 Jul 25;81(8):1222-1230
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Enhancement of Nitric Oxide Production Is Responsible for Minimal Intimal Hyperplasia of Autogenous Rabbit Arterial Grafts.
  • BACKGROUND: Vascular endothelium induces smooth muscle cell (SMC) relaxation mainly mediated by endothelium-derived nitric oxide (EDNO) and endothelium-derived hyperpolarizing factor (EDHF).
  • It has previously been reported that functions of these endothelium factors have been greatly impaired in vein grafts.
  • The present study was undertaken to determine whether the functions of EDNO and EDHF might be altered in artery graft.Methods and Results:In rabbits, the right carotid artery was excised and implanted in its original position as an autogenous graft ("artery graft") and the non-operated left carotid artery served as the "control artery".
  • Histochemical changes, acetylcholine (ACh)-induced effects on the intracellular concentration of Ca<sup>2+</sup>([Ca<sup>2+</sup>]<sub>i</sub>) in endothelial cells, endothelium-dependent SMC hyperpolarization and relaxation, and tissue cGMP content were examined on post-operative day 28.
  • When compared with the "control artery", it exhibited greater ACh-induced, endothelium-dependent relaxation, but the reverse was true when EDNO production was blocked.
  • In the "artery graft" (vs. the "control artery"), basal cGMP content was greater, whereas the [Ca<sup>2+</sup>]<sub>i</sub>increase in endothelial cells and the endothelium-dependent SMC-hyperpolarization induced by ACh were less.
  • CONCLUSIONS: It is suggested that the [Ca<sup>2+</sup>]<sub>i</sub>-independent EDNO production covers the loss of function of endothelium-dependent SMC hyperpolarization and minimizes intimal hyperplasia caused by surgical operation in autogenous carotid artery graft.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28381695.001).
  • [ISSN] 1347-4820
  • [Journal-full-title] Circulation journal : official journal of the Japanese Circulation Society
  • [ISO-abbreviation] Circ. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Keywords] NOTNLM ; Acetylcholine / Calcium-activated K+ channels / Endothelial cell Ca2+ concentration / Endothelium-dependent smooth muscle cell hyperpolarization / Nitric oxide
  •  go-up   go-down


Advertisement
4. Bregar D, Cilenšek I, Mankoč S, Reschner A, Petrovič D, Globočnik Petrovič M: The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy. Bosn J Basic Med Sci; 2017 Aug 17;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy.
  • Increasing evidence suggests that endothelin and nitric oxide synthase genes and their products exert biological effects on the vasculature via the nitric oxide or endothelin pathway.
  • We genotyped the single nucleotide polymorphism rs10507875 of the endothelin receptor B gene (EDNRB) and variable number tandem repeats rs869109213 of the nitric oxide synthase 3 gene (NOS3) in 270 Slovenian patients with DR and T2DM and 256 controls with T2DM without clinical signs of DR.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28817788.001).
  • [ISSN] 1840-4812
  • [Journal-full-title] Bosnian journal of basic medical sciences
  • [ISO-abbreviation] Bosn J Basic Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Bosnia and Herzegovina
  •  go-up   go-down


5. Deerojanawong J, Leartphichalak P, Chanakul A, Sritippayawan S, Samransamruajkit R: Exhaled nitric oxide, pulmonary function, and disease activity in children with systemic lupus erythematosus. Pediatr Pulmonol; 2017 Oct;52(10):1335-1339

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exhaled nitric oxide, pulmonary function, and disease activity in children with systemic lupus erythematosus.
  • AIM: To determine the association among fractional exhaled nitric oxide (FENO), pulmonary function, and disease activity in children with systemic lupus erythematosus (SLE).
  • All eligible participants had disease activity, FENO, and pulmonary function evaluated and re-evaluated at 6-month follow-up.
  • At baseline, 20.8% had abnormal pulmonary functions (all restrictive defects) and increased to 29.2% at follow-up (isolated restrictive defect 25% and restrictive with diffusion defect 4.2%).
  • Most of their disease activities at baseline and second assessment were non-active (58.3%, 70.8%) or mild disease activities (20.8% both).
  • FENO should be considered as an additional pulmonary function to evaluate disease activity in children with SLE.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Wiley Periodicals, Inc.
  • (PMID = 28544706.001).
  • [ISSN] 1099-0496
  • [Journal-full-title] Pediatric pulmonology
  • [ISO-abbreviation] Pediatr. Pulmonol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; children / disease activity / fractional exhaled nitric oxide / pulmonary function / systemic lupus erythematosus
  •  go-up   go-down


6. Madhu BP, Singh KP, Saminathan M, Singh R, Shivasharanappa N, Sharma AK, Malik YS, Dhama K, Manjunatha V: Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice. Virusdisease; 2016 Dec;27(4):387-399

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice.
  • : Rabies virus (RABV) stimulates nitric oxide (NO) production, which either triggers T cell differentiation or suppresses T cell function depending on its concentration.
  • The experimental animals were divided into four groups and 100LD<sub>50</sub> of challenge virus standard (CVS) strain of RABV was inoculated intracerebrally on day 0 and subsequently aminoguanidine (AG; inducible nitric oxide synthase inhibitor) was injected intraperitoneally twice a day, up to 6 days.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28004019.001).
  • [ISSN] 2347-3584
  • [Journal-full-title] Virusdisease
  • [ISO-abbreviation] Virusdisease
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; Aminoguanidine / CD4+ / CD8+ T lymphocytes / Challenge virus standard strain / Natural killer cells / Rabies virus
  •  go-up   go-down


7. Al-Ali MK, Howarth PH: Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia. Saudi Med J; 2001 Mar;22(3):249-53
Hazardous Substances Data Bank. NITRIC OXIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia.
  • OBJECTIVE: Nitric oxide is known to be present in the exhaled air of normal subjects and at higher concentrations in asthmatics.
  • The aim of this study was to measure exhaled nitric oxide levels in patients admitted to hospital with acute exacerbations of asthma, or chronic obstructive pulmonary disease, or with pneumonia.
  • METHODS: Within 24 hours of admission exhaled nitric oxide levels were measured by a chemiluminescent analyzer in 11 patients with acute sever asthma, 19 patients with acute exacerbation of chronic obstructive pulmonary disease, and in 12 patients with pneumonia.
  • RESULTS: On admission median exhaled nitric oxide levels (range) were significantly higher in asthmatics 22 (9.3-74) parts per billion in comparison to patients with chronic obstructive pulmonary disease 10.3 (2.7-34) parts per billion; p < 0.01, pneumonia 7 (4-17) parts per billion; p<0.001, and normal subjects 8.7 (5-13.3) parts per billion; p < 0.001.
  • Following treatment the asthmatics had a significant reduction in their exhaled nitric oxide levels from 22 (9.3-74) parts per billion on day 1 to 9.7 (5.7-18.3) parts per billion on day 28; p = 0.005.
  • A strong negative correlation existed between peak expiratory flow rate measurements and exhaled nitric oxide levels in asthmatics on day 28 (r = -0.70; p = 0.017).
  • CONCLUSION: Acute exacerbations of asthma are associated with increased levels of exhaled nitric oxide in contrast to exacerbations of chronic obstructive pulmonary disease and acute pneumonia.
  • Exhaled nitric oxide may be a useful indirect marker of asthmatic airway inflammation.
  • The differing time course of response of nitric oxide to peak flow measures suggests that these two measures are reflecting differing airway events.
  • [MeSH-major] Asthma / metabolism. Breath Tests. Lung Diseases, Obstructive / metabolism. Nitric Oxide / analysis. Pneumonia / metabolism


8. Guillen-Del Castillo A, Sánchez-Vidaurre S, Simeón-Aznar CP, Cruz MJ, Fonollosa-Pla V, Muñoz X: Prognostic Role of Exhaled Breath Condensate pH and Fraction Exhaled Nitric Oxide in Systemic Sclerosis Related Interstitial Lung Disease. Arch Bronconeumol; 2017 Mar;53(3):120-127
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic Role of Exhaled Breath Condensate pH and Fraction Exhaled Nitric Oxide in Systemic Sclerosis Related Interstitial Lung Disease.
  • [Transliterated title] Valor pronóstico del pH en el condensado de aire exhalado y de la fracción exhalada de óxido nítrico en la enfermedad pulmonar intersticial asociada a esclerosis sistémica.
  • METHODS: Fraction exhaled nitric oxide (FeNO) and exhaled carbon monoxide (eCO) measured in EB, together with pH, nitrite, nitrate and interleukin-6 levels measured in EBC were prospectively analyzed in 35 patients with SSc.
  • EB and EBC biomarkers were determined at inclusion, and pulmonary function tests were annually performed during 4 years of follow-up.
  • In all patients studied, low EBC pH levels were associated with a decreased diffusing capacity for carbon monoxide (DLCO) during follow-up.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.
  • (PMID = 28038794.001).
  • [ISSN] 1579-2129
  • [Journal-full-title] Archivos de bronconeumologia
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] eng; spa
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  • [Keywords] NOTNLM ; Aire exhalado / Enfermedad pulmonar intersticial / Esclerosis sistémica / Exhaled breath / Interstitial lung disease / Nitric oxide / Systemic sclerosis / pH / Óxido nítrico
  •  go-up   go-down


9. Endo A, Ayusawa M, Minato M, Takada M, Takahashi S, Harada K: Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn. Eur J Pediatr; 2001 Apr;160(4):217-22
Hazardous Substances Data Bank. NITRIC OXIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn.
  • We studied changes in endogenous nitric oxide (NO) synthesis and endothelin-1 (ET-1) production in infants with persistent pulmonary hypertension of the newborn (PPHN).
  • CONCLUSION: Limited endogenous nitric oxide synthesis and elevated endogenous endothelin-1 production during the first few days of life may contribute to pulmonary hypertension in infants with persistent pulmonary hypertension of the newborn.
  • [MeSH-major] Endothelin-1 / blood. Nitric Oxide / blood. Persistent Fetal Circulation Syndrome / blood

  • Genetic Alliance. consumer health - Pulmonary Hypertension.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11317642.001).
  • [ISSN] 0340-6199
  • [Journal-full-title] European journal of pediatrics
  • [ISO-abbreviation] Eur. J. Pediatr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Endothelin-1; 31C4KY9ESH / Nitric Oxide
  •  go-up   go-down


10. Sevgili AM, Balkanci DZ, Erdem A: Potential excitatory role of nitric oxide on 2-deoxy-d-glucose-induced gastric motility in rats. Clin Exp Pharmacol Physiol; 2017 Jun;44(6):693-699

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Potential excitatory role of nitric oxide on 2-deoxy-d-glucose-induced gastric motility in rats.
  • Since nitric oxide (NO) is involved in gastric motility, a possible interplay between 2-DG and NO can be suggested.
  • In the present study, Wistar rats (250-350 g) of both sexes were intravenously injected with 2-DG (200 mg/kg), and the effects of the intravenous injection of the nitric oxide synthase (NOS) inhibitors; nitro-l-arginine methyl ester (l-NAME, 10 mg/kg) and N<sup>ω</sup> -nitro-l-arginine (l-NNA, 10 mg/kg) were investigated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 John Wiley & Sons Australia, Ltd.
  • (PMID = 28294385.001).
  • [ISSN] 1440-1681
  • [Journal-full-title] Clinical and experimental pharmacology & physiology
  • [ISO-abbreviation] Clin. Exp. Pharmacol. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Keywords] NOTNLM ; 2-deoxy-d-glucose / Wistar / gastric motility / intragastric pressure / l-NAME / l-NNA / motility index / nitric oxide / rat
  •  go-up   go-down






Advertisement